Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 10Fabrazyme
02 1Replagal
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Rare Disorders
Currency : USD
2019 Revenue in Millions : 886
2018 Revenue in Millions : 823
Growth (%) : 8
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Rare Disorders
Currency : USD
2020 Revenue in Millions : 988
2019 Revenue in Millions : 983
Growth (%) : 0
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Rare Disorders
Currency : USD
2021 Revenue in Millions : 929
2020 Revenue in Millions : 891
Growth (%) : 3
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Rare Diseases
Currency : USD
2022 Revenue in Millions : 1,029
2021 Revenue in Millions : 929
Growth (%) : 11
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Rare Diseases
Currency : USD
2023 Revenue in Millions : 1,070
2022 Revenue in Millions : 1,029
Growth (%) : 6
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Rare Disease
Currency : USD
2014 Revenue in Millions : 20.10%
2013 Revenue in Millions :
Growth (%) :
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Rare Disease
Currency : USD
2015 Revenue in Millions : 506
2014 Revenue in Millions : 651
Growth (%) : 29%
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Rare Diseases
Currency : USD
2016 Revenue in Millions : 714
2015 Revenue in Millions : 628
Growth (%) : 14
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Rare Diseases
Currency : USD
2017 Revenue in Millions : 895
2016 Revenue in Millions : 836
Growth (%) : 7
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Rare Diseases
Currency : USD
2018 Revenue in Millions : 853
2017 Revenue in Millions : 816
Growth (%) : 5%
LOOKING FOR A SUPPLIER?